CollaGenex Pharmaceuticals Initiates Two Phase 3 Clinical Trials to Evaluate Col-101 for the Treatment of Rosacea.
Permanent Link:
http://vlex.com/vid/collagenex-evaluate-col-101-rosacea-53249030
Id. vLex: VLEX-53249030
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
CollaGenex Pharmaceuticals Initiates Two Phase 3 Clinical Trials to Evaluate Col-101 for the Treatment of Rosacea.
Business Editors/Health/Medical Writers
NEWTOWN, Pa.--(BUSINESS WIRE)--June 15, 2004 CollaGenex Pharmaceuticals, Inc. (Nasdaq:CGPI) today announced that the FDA has cleared the way for the immediate enrollment of patients in two Phase 3 clinical trials of Col-101, the Company's once daily, modified-release formulation of doxycycline, 40 mg, for the ...Try vLex for FREE for 3 days
Access legal information from United States including:
- Constitutions
- Forms and Contracts
- Legal Books and Journals
- Case Law
- News and Business
- Regulations
- U.S. Code
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here
Other documents:
ANUNCI de l Ajuntament de Vilablareix sobre aprovació d un pla local de joventut.
|
Edicto (4637/2007).
|
Case nº 242/2002 of Audiencia Provincial Sevilla of October 23 2002
|
Missing Women Activist's Mission |
Acordao Inteiro Teor n AIRR-69366/2002-900-02-00.6 of 1 Turma of February 15 2006
|
Decisão Monocrática Nº 2005/0003539-2 of Superior Tribunal de Justiça Presidência of March 09 2007
|
El acta amenaza a Zidane |
Europaparlamentets och rAdets beslut nr 283/1999/EG av den 25 januari 1999 om inrAttand... |
Spich, naamloze vennootschap, De Smet de Naeyerlaan 28, Oostende H.R. Oostende 29062 BTW 407.255.785 De aandeelhoude... |
Un catalán al frente del banco público
